| Followers | 0 |
| Posts | 63269 |
| Boards Moderated | 4 |
| Alias Born | 06/06/2012 |
Friday, October 08, 2021 7:45:04 AM
I bet we see even more volume as investors are starting so see the value here..
Recent AINMF News
- NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset • GlobeNewswire Inc. • 03/25/2026 11:00:00 AM
- NetraMark Unveils AI-Discovered Treatment-Responsive Subgroups in A4 Alzheimer’s Trial at AD/PD Conference • GlobeNewswire Inc. • 03/19/2026 11:00:00 AM
- NetraMark Signs Contract With Global Biopharmaceutical Company to Analyze Phase 2 Depression Trial Data • GlobeNewswire Inc. • 03/11/2026 11:00:00 AM
- NetraMark Closes Final Tranche of $3.5 Million Private Placement • GlobeNewswire Inc. • 02/19/2026 12:00:00 PM
- Netramark Announces Uplisting to Toronto Stock Exchange • GlobeNewswire Inc. • 02/13/2026 12:00:00 PM
- NetraMark Strengthens Board Of Directors • GlobeNewswire Inc. • 01/29/2026 01:30:00 PM
- NetraMark Closes First Tranche of Private Placement • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- NetraMark Engages LodeRock Advisors for Strategic Investor Relations and Capital Markets Communications Services • GlobeNewswire Inc. • 01/22/2026 01:30:00 PM
- NetraMark Announces Private Placement Financing • GlobeNewswire Inc. • 01/13/2026 01:30:00 PM
- NetraMark Delivers Transformational Quarter Of Execution • GlobeNewswire Inc. • 12/18/2025 01:30:00 PM
- NetraMark and CAMH Announce Research Award to Advance AI-Driven Discovery in Schizophrenia and Depression • GlobeNewswire Inc. • 12/16/2025 01:30:00 PM
- NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company • GlobeNewswire Inc. • 12/11/2025 01:30:00 PM
- NetraAI Study Accepted for Publication in npj Digital Medicine, Part of the Nature Portfolio • GlobeNewswire Inc. • 12/08/2025 01:30:00 PM
- NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights • GlobeNewswire Inc. • 11/18/2025 01:30:00 PM
- Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights • GlobeNewswire Inc. • 11/03/2025 01:30:00 PM
- NetraMark Presents AI-Driven Advances in Precision Psychiatry to Enhance Clinical Trial Designs at Joint Autumn Conference • GlobeNewswire Inc. • 10/29/2025 10:30:00 AM
- NetraMark Initiates AI-Driven Collaboration in Glioblastoma Research • GlobeNewswire Inc. • 09/22/2025 12:30:00 PM
